The EpiCURA Hospital Center announced Tuesday in a press release that its radiotherapy center has obtained the prestigious Novalis certification. This distinction is a testament to the center’s commitment to the quality and safety of the care provided to its patients. Novalis certification attests to the center’s compliance with the highest standards in stereotactic treatment.
Stereotaxic treatments are high-precision interventions targeting small tumors located either in the cranium or in other organs such as the lungs, liver, bones, and prostate. In 2017, the EpiCURA radiotherapy center acquired two latest generation accelerators, including one specifically dedicated to radiosurgery and intra and extracerebral stereotaxy. Since this acquisition, the radiotherapy team has implemented procedures and protocols that rigorously comply with the strictest quality standards.
This approach to excellence has made it possible to standardize practices, optimize coordination between the different professionals involved, and strengthen ongoing staff training. In addition, it has promoted better identification and resolution of preventive risks, thus ensuring the safety and effectiveness of treatments for patients.
EpiCURA is delighted with the work accomplished by its team and the international recognition of its good practices. “We are honored and proud to receive this certification, which demonstrates our commitment to providing high-quality care. This is the result of the hard work and determination of our team, as well as our commitment to innovation and continuous improvement,” said Dr. Sara Van Brussel, Head of Radiotherapy-Oncology.
Access to all features is reserved for healthcare professionals.
If you are a healthcare professional you must log in or register for free on our site to access all of our content.
If you are a journalist or if you wish to inform us, write to us at [email protected].
